Recent Advancements in AD Treatment

Opinion
Video

An expert discusses the advancements in systemic and targeted therapies that have had the most significant impact on atopic dermatitis (AD) treatment in recent years as well as the cost-effectiveness and real-world outcomes of biologics and Janus kinase (JAK) inhibitors compared with traditional systemic therapies for AD

Video content above is prompted by the following:

  1. In your opinion, what advancements in systemic and targeted therapies have had the most significant impact on AD treatment in recent years?
  2. Based on your experience, how do the cost-effectiveness and real-world outcomes of biologics and JAK inhibitors compare with traditional systemic therapies for AD in your patient population?
Recent Videos
2 experts are featured in this series.
2 experts in this video
2 experts in this video
1 expert in this video
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.